This allowed us to investigate hypercoagulation as defined by thrombin release and generation by breast cancer cells with ensuing effects on platelet activation identified by CD62P/P-selectin and lysosome membrane protein 3 (LAMP3)/CD63 expression, with corresponding platelet morphological alterations. This evidence concerns the gene CD63 and breast carcinoma.